Sorafenib as first line treatment for advanced liver cancer - are expiries

Наслов

Sorafenib as first line treatment for advanced liver cancer - are expiries

Идентификатор

/unibl/sci/idNaucniRad:25647

Тип

Датум

Библиографски цитат

Z. Gojković, S. Jungić, I. Rakita, Ž. Vranješ, R. Rašeta, G. Marić, M. Vještica, S. Mijatović, P. Dašić, M. Vižin, J. Rožić, Sorafenib as first line treatment for advanced liver cancer - are expiries, Annals of Oncology 2012; 23(4) iv57, 2012

Презентовано

Annals of Oncology

Је дио

Annals of Oncology 2012; 23(4) iv57

Листа аутора

Position: 4470 (49 views)